Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.
The Opportunity:
The Commercial Lead in the Netherlands is responsible for defining and executing the local commercial strategy for RevMEd portfolio and launches. This role is accountable for building the commercial organization, driving launch and growth performance, and ensuring strong alignment across Medical Affairs, Market Access, and other key functions.
The incumbent will proactively identify and address relevant systemic opportunities and barriers, including healthcare structures, competitor dynamics, data gaps, diagnostic challenges, and advocacy needs, as well as HCP-related opportunities such as therapeutic gaps, differentiation, economic value attributes, and clear communication of patient- and physician-relevant benefits.
The Commercial Lead in the Netherlands will oversee the generation of insights from the therapeutic field and translate these insights into a comprehensive, cross-functional commercial strategy. In support of clear positioning and an aligned communication approach, the incumbent will also ensure the development and implementation of tactics and tools that enable the field force to effectively address customer needs.
Responsibilities:
Act as the commercial lead for Netherlands, accountable for local commercial strategy, execution, and performance across the oncology portfolio.
Serve as a core member of the Netherlands Leadership Team, contributing to country strategy, launch planning, and key business decisions.
Partner with regional and local Medical Affairs and Market Access teams to translate clinical and economic evidence into compelling value communications tailored to Netherlands stakeholders, including HCPs and payers.
Translate regional and global commercial strategies into locally optimized plans aligned with Netherlands market dynamics, customer needs, and healthcare system requirements, in close collaboration with the European commercial team.
Represent Netherlands in regional commercial discussions and contribute country insights to shape broader commercial plans and strategy.
Develop and execute country-level brand and portfolio strategies across pre-launch, launch, and post-launch phases.
Drive demand generation and appropriate use through non-promotional and promotional channels, in compliance with local regulations.
Lead forecasting, budgeting, and operational planning for the country in close collaboration with the ED, Commercial Excellence, Business Analytics and Insights, Europe.
Lead commercial launch readiness for oncology products, including customer strategy, segmentation, targeting, and field force planning.
Partner closely with Medical Affairs and Market Access to ensure integrated launch execution and consistent external engagement.
Monitor performance, competitive dynamics, and market trends, adjusting strategy and execution as needed.
Oversee engagement strategy across key stakeholders, including oncologists, treatment centers, and healthcare organizations.
Ensure effective field force deployment and capability building.
Build, lead, and develop the country commercial organization, including sales, marketing, and customer-facing roles as the business scales.
Establish commercial processes, governance, and ways of working as part of the country build-out.
Foster a culture of accountability, collaboration, and performance excellence.
Contribute to regional and country-specific initiatives.
Travel nationally and internationally as required.
Required Skills, Experience and Education:
Advanced degree required, such as MSc, PhD, MD, or PharmD.
10+ years of experience in pharmaceutical or biotech commercial roles.
Significant experience in oncology commercial leadership in Netherlands.
Proven track record of successful oncology product launches in Netherlands and successful engagement with HCPs and KOLs.
Excellent communication skills, both in person and virtual.
Scientific and solution-oriented mindset, with the ability to operate and execute effectively in a rapidly changing and ambiguous environment.
Strong understanding of the Netherlands healthcare system, customer dynamics, and reimbursement environment.
Proven leadership and people management capabilities, with demonstrated success in a small, fast-growing, entrepreneurial commercial environment.
High degree of social competence, with strong capabilities in teamwork, coaching, and situational leadership.
Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact [email protected].
#LI-Hybrid #LI-LO1
We are aware of recent recruitment scams in which individuals or organizations falsely represent themselves as being affiliated with Revolution Medicines. These scams may appear as false job advertisements or unsolicited contacts through communication or chat platforms, email, phone, or text message.
Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process. All legitimate communication from Revolution Medicines will come from an official @revmed.com email address.
If you believe you’ve been contacted by someone impersonating a Revolution Medicines recruiter, please report it to [email protected] so we can share these impersonations with our IT team for tracking and awareness.
Skills Required
- Advanced degree (MSc, PhD, MD, or PharmD)
- 10+ years of experience in pharmaceutical or biotech commercial roles
- Significant oncology commercial leadership experience in the Netherlands
- Proven track record of successful oncology product launches in the Netherlands
- Proven engagement with HCPs and KOLs
- Excellent communication skills, in-person and virtual
- Scientific and solution-oriented mindset, able to operate in ambiguity
- Strong understanding of the Netherlands healthcare system and reimbursement environment
- Proven leadership and people management capabilities in a fast-growing commercial environment
- High social competence: teamwork, coaching, and situational leadership
- Willingness to travel nationally and internationally as required
What We Do
We are Revolutionaries – passionate in our singular pursuit of discovering, developing and delivering innovative, targeted medicines for patients living with cancer. To deliver on our vision, we work relentlessly in pursuit of cutting-edge therapeutic approaches to some of the toughest cancers. Our current focus is on RAS-addicted cancers, which account for 30 percent of all new human cancer diagnoses
